28283889|t|CF3DODA-Me induces apoptosis, degrades Sp1, and blocks the transformation phase of the blebbishield emergency program
28283889|a|Cancer stem cells are capable of undergoing cellular transformation after commencement of apoptosis through the blebbishield emergency program in a VEGF - VEGFR2 - dependent manner. Development of therapeutics targeting the blebbishield emergency program would thus be important in cancer therapy. Specificity protein 1 (Sp1) orchestrates the transcription of both VEGF and VEGFR2; hence, Sp1 could act as a therapeutic target. Here, we demonstrate that CF3DODA-Me induced apoptosis, degraded Sp1, inhibited the expression of multiple drivers of the blebbishield emergency program such as VEGFR2, p70S6K, and N-Myc through activation of caspase-3, inhibited reactive oxygen species; and inhibited K-Ras activation to abolish transformation from blebbishields as well as transformation in soft agar. These findings confirm CF3DODA-Me as a potential therapeutic candidate that can induce apoptosis and block transformation from blebbishields.
28283889	0	10	CF3DODA-Me	T103	UMLS:C1254351
28283889	19	28	apoptosis	T038	UMLS:C0162638
28283889	39	42	Sp1	T103	UMLS:C0080245
28283889	59	73	transformation	T038	UMLS:C0040682
28283889	87	117	blebbishield emergency program	T038	UMLS:C0007613
28283889	118	135	Cancer stem cells	T017	UMLS:C1956422
28283889	162	185	cellular transformation	T038	UMLS:C1510411
28283889	208	217	apoptosis	T038	UMLS:C0162638
28283889	230	260	blebbishield emergency program	T038	UMLS:C0007613
28283889	266	270	VEGF	T103	UMLS:C1256770
28283889	273	279	VEGFR2	T103	UMLS:C0378796
28283889	315	327	therapeutics	T058	UMLS:C0087111
28283889	328	337	targeting	T038	UMLS:C0599894
28283889	342	372	blebbishield emergency program	T038	UMLS:C0007613
28283889	400	414	cancer therapy	T058	UMLS:C0920425
28283889	416	437	Specificity protein 1	T103	UMLS:C0080245
28283889	439	442	Sp1	T103	UMLS:C0080245
28283889	461	474	transcription	T038	UMLS:C0040649
28283889	483	487	VEGF	T017	UMLS:C1823619
28283889	492	498	VEGFR2	T017	UMLS:C1334306
28283889	507	510	Sp1	T103	UMLS:C0080245
28283889	572	582	CF3DODA-Me	T103	UMLS:C1254351
28283889	591	600	apoptosis	T038	UMLS:C0162638
28283889	611	614	Sp1	T103	UMLS:C0080245
28283889	630	640	expression	T038	UMLS:C1171362
28283889	668	698	blebbishield emergency program	T038	UMLS:C0007613
28283889	707	713	VEGFR2	T103	UMLS:C0378796
28283889	715	721	p70S6K	T103	UMLS:C0073337
28283889	727	732	N-Myc	T103	UMLS:C0079885
28283889	755	764	caspase-3	T103	UMLS:C0291573
28283889	776	799	reactive oxygen species	T103	UMLS:C0162772
28283889	815	820	K-Ras	T103	UMLS:C0079973
28283889	843	857	transformation	T038	UMLS:C0040682
28283889	863	876	blebbishields	T017	UMLS:C0243092
28283889	888	902	transformation	T038	UMLS:C0040682
28283889	906	915	soft agar	T103	UMLS:C0001771
28283889	932	939	confirm	T033	UMLS:C0750484
28283889	940	950	CF3DODA-Me	T103	UMLS:C1254351
28283889	978	987	candidate	T103	UMLS:C1254351
28283889	1004	1013	apoptosis	T038	UMLS:C0162638
28283889	1024	1038	transformation	T038	UMLS:C0040682
28283889	1044	1057	blebbishields	T017	UMLS:C0243092